These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 38303495)

  • 1. Recent advancements in the diagnosis and treatment of acral melanoma.
    Alhaskawi A; Ezzi SHA; Dong Y; Zhou H; Wang Z; Lai J; Yao C; Kota VG; Abdulla MHAH; Lu H
    J Zhejiang Univ Sci B; 2024 Feb; 25(2):106-122. PubMed ID: 38303495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.
    Darmawan CC; Jo G; Montenegro SE; Kwak Y; Cheol L; Cho KH; Mun JH
    J Am Acad Dermatol; 2019 Sep; 81(3):805-812. PubMed ID: 30731177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Narrative Review of the Evolution of Diagnostic Techniques and Treatment Strategies for Acral Lentiginous Melanoma.
    Choi ME; Choi EJ; Jung JM; Lee WJ; Jo YS; Won CH
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Acral Pigmented Lesions.
    Ingrassia JP; Stein JA; Levine A; Liebman TN
    Dermatol Surg; 2023 Oct; 49(10):926-931. PubMed ID: 37556446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Management of Acral Lentiginous Melanoma.
    Nakamura Y; Fujisawa Y
    Curr Treat Options Oncol; 2018 Jun; 19(8):42. PubMed ID: 29951919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management.
    Desai A; Ugorji R; Khachemoune A
    Clin Exp Dermatol; 2018 Mar; 43(2):117-123. PubMed ID: 29235153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients.
    Takai S; Arai E; Shojiguchi N; Nakamura Y; Momose S; Fukuda T; Ishizawa K; Ogata D; Tsunemi Y; Nakamura K; Tsuchida T
    J Dermatol; 2023 May; 50(5):637-645. PubMed ID: 36539950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acral melanoma with satellitosis, disguised as a longstanding diabetic ulcer: a great mimicry.
    Mansur AT; Demirci GT; Ozel O; Ozker E; Yıldız S
    Int Wound J; 2016 Oct; 13(5):1006-8. PubMed ID: 26400657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key points in dermoscopic differentiation between early acral melanoma and acral nevus.
    Saida T; Koga H; Uhara H
    J Dermatol; 2011 Jan; 38(1):25-34. PubMed ID: 21175752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological diagnosis of acral lentiginous melanoma in early stages.
    Fernandez-Flores A; Cassarino DS
    Ann Diagn Pathol; 2017 Feb; 26():64-69. PubMed ID: 27601330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.
    Jung S; Johnson DB
    Oncologist; 2022 Aug; 27(8):703-710. PubMed ID: 35640549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subungual melanoma: a deceptive disorder.
    Patel GA; Ragi G; Krysicki J; Schwartz RA
    Acta Dermatovenerol Croat; 2008; 16(4):236-42. PubMed ID: 19111151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Therapy and Immunotherapy for Melanoma in Japan.
    Namikawa K; Yamazaki N
    Curr Treat Options Oncol; 2019 Jan; 20(1):7. PubMed ID: 30675668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
    Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
    Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas?
    Lim Y; Lee J; Lee DY
    J Dermatol; 2020 Mar; 47(3):251-256. PubMed ID: 31889335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
    Mao L; Qi Z; Zhang L; Guo J; Si L
    Front Immunol; 2021; 12():680407. PubMed ID: 34149718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational pathology, genomics and the development of systemic therapies for acral melanoma.
    Chen YA; Teer JK; Eroglu Z; Wu JY; Koomen JM; Karreth FA; Messina JL; Smalley KSM
    Semin Cancer Biol; 2020 Apr; 61():149-157. PubMed ID: 31689494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral Lentiginous Melanoma - misdiagnosis, referral delay and 5 years specific survival according to site.
    Boriani F; O'Leary F; Tohill M; Orlando A
    Eur Rev Med Pharmacol Sci; 2014; 18(14):1990-6. PubMed ID: 25027337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral Lentiginous Melanoma.
    Goydos JS; Shoen SL
    Cancer Treat Res; 2016; 167():321-9. PubMed ID: 26601870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than just acral melanoma: the controversies of defining the disease.
    Bernardes SS; Ferreira I; Elder DE; Nobre AB; Martínez-Said H; Adams DJ; Robles-Espinoza CD; Possik PA
    J Pathol Clin Res; 2021 Nov; 7(6):531-541. PubMed ID: 34213090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.